Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Current Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Total Current Liabilities ₹107 Cr₹113 Cr₹78 Cr₹59 Cr₹66 Cr

What is the latest Total Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹107 Cr based on Mar2024 Consolidated results.
Year Total Current Liabilities
Mar2024₹107 Cr
Mar2023₹113 Cr
Mar2022₹78 Cr
Mar2017₹59 Cr
Mar2016₹66 Cr

How is Total Current Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Current Liabilities % Change
Mar2024 ₹107 Cr
-5.86
Mar2023 ₹113 Cr
44.60
Mar2022 ₹78 Cr
33.01
Mar2017 ₹59 Cr
-10.43
Mar2016 ₹66 Cr -

Compare Total Current Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹2,084.0 Cr 4.7% 34.5% 82.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,824.0 Cr 0.5% -0.5% 14.6% Stock Analytics
DIVIS LABORATORIES ₹178,355.0 Cr 1.3% 10.7% 49.3% Stock Analytics
CIPLA ₹122,929.0 Cr 2.2% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹112,701.0 Cr 4.7% 11.9% 14.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹108,502.0 Cr 2% -0.8% 15.7% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

4.7%

34.5%

82.8%

SENSEX

1.9%

0.1%

10.9%


You may also like the below Video Courses